Болезни билиарного тракта в контексте ассоциации с онкологическими заболеваниями пищеварительной системы

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30. doi: 10.3322/caac.21166
2. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена Филиал ФГБУ «НМИЦ Радиологии» Минздрава России, 2018 [Kaprin AD, Starinskiy VV, Petrova GV, eds. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Moscow: MNIOI im. P.A. Gertsena Filial FGBU «NMITs Radiologii» Minzdrava Rossii, 2018 (In Russ.)].
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi: 10.3322/caac.20107
4. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-386. doi: 10.1002/ijc.29210
5. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230-9. doi: 10.1016/S0140-6736(06)69044-2
6. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136(2):376-86. doi: 10.1053/j.gastro.2008.12.015
7. Farthing M, Roberts SE, Samuel DG, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe. United European Gastroenterol J. 2014;2(6):539-43. doi: 10.1177/2050640614554154
8. Rodriguez S, Gaunt TR, Guo Y, et al. Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular gene-centric 50K SNP array. Eur J Hum Genet. 2016;24(1):106-12. doi: 10.1038/ejhg.2015.63
9. Fukuma H, Morshed SA, Watanabe S, et al. Increased expression of cytokines in liver and serum in patients with extrahepatic diseases. J Gastroenterol. 1996;31(4):538-45.
10. Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012;143(3):550-63. doi: 10.1053/j.gastro.2012.07.009
11. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-99. doi: 10.1016/j.cell.2010.01.025
12. Abbas T, Keaton MA, Dutta A. Genomic instability in cancer. Cold Spring Harb Perspect Biol. 2013;5(3):a012914. doi: 10.1101/cshperspect.a012914
13. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1-9. doi: 10.1016/j.critrevonc.2007.07.004
14. Zang J, Yuan Y, Zhang C, Gao J. Elective laparoscopic cholecystectomy without intraoperative cholangiography: role of preoperative magnetic resonance cholangiopancreatography – a retrospective cohort study. BMC Surg. 2016;16(1):45. doi: 10.1186/s12893-016-0159-9
15. Holzheimer RG, Mannick JA, eds. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt; 2001. Accessed July 03, 2019. http://www.ncbi.nlm.nih.gov/books/NBK6880/
16. Mahid SS, Jafri NS, Brangers BC, Minor KS, Hornung CA, Galandiuk S. Meta-analysis of cholecystectomy in symptomatic patients with positive hepatobiliary iminodiacetic acid scan results without gallstones. Arch Surg. 2009;144(2):180-7. doi: 10.1001/archsurg.2008.543
17. Sonne DP, Hare KJ, Martens P, et al. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients. Am J Physiol Gastrointest Liver Physiol. 2013;304(4):G413-419. doi: 10.1152/ajpgi.00435.2012
18. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137-74. doi: 10.1146/ annurev.biochem.72.121801.161712
19. Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med. 1999;159(22):2647-58.
20. Chiang JYL. Bile acids: regulation of synthesis. J Lipid Res. 2009;50(10):1955-66. doi: 10.1194/jlr.R900010-JLR200
21. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry. 1992;31(20):4737-49.
22. Ridlon JM, Kang D-J, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241-59. doi: 10.1194/jlr.R500013-JLR200
23. Chiang JYL. Bile Acid Metabolism and Signaling. Compr Physiol. 2013;3(3):1191-212. doi: 10.1002/cphy.c120023
24. Di Ciaula A, Garruti G, Lunardi Baccetto R, et al. Bile Acid Physiology. Ann Hepatol. 2017;16:S4-S14. doi: 10.5604/01.3001.0010.5493
25. Staley C, Weingarden AR, Khoruts A, Sadowsky MJ. Interaction of Gut Microbiota with Bile Acid Metabolism and its Influence on Disease States. Appl Microbiol Biotechnol. 2017;101(1):47-64. doi: 10.1007/s00253-016-8006-6
26. Chen Y-K, Yeh J-H, Lin C-L, et al. Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study. J Gastroenterol. 2014;49(5):923-31. doi: 10.1007/s00535-013-0846-6
27. Bernstein C, Holubec H, Bhattacharyya AK, et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol. 2011;85(8):863-71. doi: 10.1007/s00204-011-0648-7
28. Reddy BS, Wynder EL. Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer. 1977;39(6):2533-9.
29. Huo X, Juergens S, Zhang X, et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett’s epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2011;301(2):G278-286. doi: 10.1152/ajpgi.00092.2011
30. Wang X, Sun L, Wang X, et al. Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression. Cancer Med. 2017;6(4):788-97. doi: 10.1002/cam4.999
31. Nagathihalli NS, Beesetty Y, Lee W, et al. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. Cancer Res. 2014;74(7):2062-72. doi: 10.1158/0008-5472.CAN-13-2329
32. Quante M, Bhagat G, Abrams JA, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 2012;21(1):36-51. doi: 10.1016/j.ccr.2011.12.004
33. Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. Inflammatory gradient in Barrett’s oesophagus: implications for disease complications. Gut. 2002;51(3):316-22.
34. Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses. 1986;19(1):57-69.
35. Tucker ON, Dannenberg AJ, Yang EK, Fahey TJ. Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis. 2004;25(3):419-23. doi: 10.1093/carcin/bgh010
36. Koga S, Kaibara N, Takeda R. Effect of bile acids on 1,2-dimethylhydrazine-induced colon cancer in rats. Cancer. 1982;50(3):543-7.
37. Zuccato E, Venturi M, Di Leo G, et al. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci. 1993;38(3):514-9.
38. Perez M-J, Briz O. Bile-acid-induced cell injury and protection. World J Gastroenterol. 2009;15(14):1677-89. doi: 10.3748/wjg.15.1677
39. Lagergren J, Mattsson F. Cholecystectomy as a risk factor for oesophageal adenocarcinoma. Br J Surg. 2011;98(8):1133-7. doi: 10.1002/bjs.7504
40. Freedman J, Ye W, Näslund E, Lagergren J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001;121(3):548-53.
41. Ge Z, Zhao C, Wang Y, Qian J. Cholecystectomy and the risk of esophageal and gastric cancer. Saudi Med J. 2012;33(10):1073-9.
42. Огнерубов Н.А. Желчнокаменная болезнь после хирургического лечения рака желудка: оправдана ли профилактическая холецистэктомия? Вестник ТГУ. 2017;22(1):148-54 [Ognerubov NA. Gallstone disease after surgical treatment of gastric cancer: is prophylactic cholecystectomy justified? Vestnik TGU. 2017;22(1):148-54 (In Russ.)]. doi: 10.20310/1810-0198-2017-22-1-148-154
43. Inoue K, Fuchigami A, Higashide S, et al. Gallbladder sludge and stone formation in relation to contractile function after gastrectomy. A prospective study. Ann Surg. 1992;215(1):19-26.
44. Hauters PP, de Neve de Roden A, Pourbaix A, Aupaix F, Coumans P, Therasse G. Cholelithiasis: a serious complication after total gastrectomy. Br J Surg. 1988;75:899-900.
45. Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y. Analysis of risks factors for the development of gallstones after gastrectomy. Br J Surg.2005;92:1399-403. doi: 10.1002/bjs.5117
46. Ichimiya H, Kono S, Ikeda M, Tokudome S, Nakayama F, Kuratsune M. Cancer mortality among patients undergoing cholecystectomy for benign biliary diseases. Jpn J Cancer Res. 1986;77(6):579-83.
47. Freedman J, Lagergren J, Bergström R, Näslund E, Nyrén O. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg. 2000;87(8):1087-93. doi: 10.1046/j.1365-2168.2000.01459.x
48. Kalima T, Sjöberg J. Bile reflux after cholecystectomy. Scand J Gastroenterol Suppl. 1981;67:153-6.
49. Kang SH, Kim YH, Roh YH, et al. Gallstone, cholecystectomy and risk of gastric cancer. Ann Hepatobiliary Pancreat Surg. 2017;21(3):131-7. doi: 10.14701/ahbps.2017.21.3.131
50. Nogueira L, Freedman ND, Engels EA, Warren JL, Castro F, Koshiol J. Gallstones, cholecystectomy, and risk of digestive system cancers. Am J Epidemiol. 2014;179(6):731-9. doi: 10.1093/aje/kwt322
51. Hardt PD, Bretz L, Krauss A, et al. Pathological pancreatic exocrine function and duct morphology in patients with cholelithiasis. Dig Dis Sci. 2001;46(3):536-9.
52. Gong Y, Li S, Tang Y, et al. Cholelithiasis and risk of pancreatic cancer: systematic review and meta-analysis of 21 observational studies. Cancer Causes Control. 2014;25(11):1543-51. doi: 10.1007/s10552-014-0458-3
53. Hyvärinen H, Partanen S. Association of cholecystectomy with abdominal cancers. Hepatogastroenterology. 1987;34(6):280-4.
54. Smith JP, Solomon TE, Bagheri S, Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci. 1990;35(11):1377-84.
55. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57(1):69-76. doi: 10.1016/ j.jhep.2012.02.022
56. Ioannou GN. Cholelithiasis, cholecystectomy, and liver disease. Am J Gastroenterol. 2010;105(6):1364-73. doi: 10.1038/ajg.2009.737
57. Guo L, Mao J, Li Y, et al. Cholelithiasis, cholecystectomy and risk of hepatocellular carcinoma: a meta-analysis. J Cancer Res Ther. 2014;10(4):834-8. doi: 10.4103/0973-1482.135992
58. Wang Y, Xie L-F, Lin J. Gallstones and cholecystectomy in relation to risk of liver cancer. Eur J Cancer Prev. 2019;28(2):61-7. doi: 10.1097/CEJ.0000000000000421
59. Liu Y, He Y, Li T, et al. Risk of primary liver cancer associated with gallstones and cholecystectomy: a meta-analysis. PLoS ONE. 2014;9(10):e109733. doi: 10.1371/journal.pone.0109733
60. Xiong J, Wang Y, Huang H, et al. Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma. Oncotarget. 2017;8(35):59648-57. doi: 10.18632/oncotarget.19570
61. Medavaram S, Zhang Y. Emerging therapies in advanced hepatocellular carcinoma. Exp Hematol Oncol. 2018;7. doi: 10.1186/s40164-018-0109-6
62. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. doi: 10.3322/caac.21442
63. Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29):5282-94. doi: 10.3748/wjg.v23.i29.5282
64. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118-27. doi: 10.1056/NEJMra1001683
65. Johansen C, Chow WH, Jørgensen T, Mellemkjaer L, Engholm G, Olsen JH. Risk of colorectal cancer and other cancers in patients with gall stones. Gut. 1996;39(3):439-43. doi: 10.1136/gut.39.3.439
66. Tavani A, Rosato V, Di Palma F, et al. History of cholelithiasis and cancer risk in a network of case-control studies. Ann Oncol. 2012;23(8):2173-8. doi: 10.1093/annonc/mdr581
67. Deschner EE, Cohen BI, Raicht RF. Acute and chronic effect of dietary cholic acid on colonic epithelial cell proliferation. Digestion. 1981;21(6):290-6. doi: 10.1159/000198579
68. Cohen BI, Raicht RF, Deschner EE, Takahashi M, Sarwal AN, Fazzini E. Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats. J Natl Cancer Inst. 1980;64(3):573-8.
69. Pomare EW, Heaton KW. The effect of cholecystectomy on bile salt metabolism. Gut. 1973;14(10):753-62.
70. El Zoghbi M, Cummings LC. New era of colorectal cancer screening. World J Gastrointest Endosc. 2016;8(5):252-8. doi: 10.4253/wjge.v8.i5.252
71. Berkhout M, Roelofs HMJ, Friederich P, et al. Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study. Transl Res. 2007;150(3):147-9. doi:10.1016/j.trsl.2007.03.009
72. Zhao M-F, Huang P, Ge C-L, Sun T, Ma Z-G, Ye F-F. Conjugated bile acids in gallbladder bile and serum as potential biomarkers for cholesterol polyps and adenomatous polyps. Int J Biol Markers. 2016;31(1):e73-79. doi: 10.5301/jbm.5000173
73. Cheng K, Metry M, Felton J, Shang AC, Drachenberg CB, Xu S, Zhan M, Schumacher J, Guo GL, Polli JE, Raufman JP. Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget. 2018;9(39):25572-85. 
74. Flynn C, Montrose DC, Swank DL, Nakanishi M, Ilsley JN, Rosenberg DW. Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Mol Carcinog. 2007;46(1):60-70. doi: 10.1002/mc.20253
75. Raufman JP, Dawson PA, Rao A, Drachenberg CB, Heath J, Shang AC, Hu S, Zhan M, Polli JE, Cheng K. Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. Carcinogenesis. 2015;36(10):1193-200. doi: 10.1093/carcin/bgv107
76. Wang W, Wang J, Li J, et al. Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction. Front Microbiol. 2018;9. doi: 10.3389/fmicb.2018.01402
77. Galitskiy M, Khomeriki S, Nikiforov P. Expression of proliferation and apoptosis markers in neoplasms of colon mucosa after cholecystectomy. Eksp Klin Gastroenterol. 2009;(5):28-32.
78. Zhang Y, Liu H, Li L, et al. Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies. PLoS ONE. 2017;12(8):e0181852. doi: 10.1371/journal.pone.0181852
79. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology. 1993;105(1):130-41.
80. Xu Y-K, Zhang F-L, Feng T, Li J, Wang Y-H. [Meta-analysis on the correlation of cholecystectomy or cholecystolithiasis to risk of colorectal cancer in Chinese population]. Ai Zheng. 2009;28(7):749-55.
81. Chiong C, Cox MR, Eslick GD. Gallstone disease is associated with rectal cancer: a meta-analysis. Scand J Gastroenterol. 2012;47(5):553-64. doi: 10.3109/00365521.2012.660538
82. Chiong C, Cox MR, Eslick GD. Gallstones are associated with colonic adenoma: a meta-analysis. World J Surg. 2012;36(9):2202-9. doi: 10.1007/s00268-012-1646-5

________________________________________________

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30. doi: 10.3322/caac.21166
2. [Kaprin AD, Starinskiy VV, Petrova GV, eds. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Moscow: MNIOI im. P.A. Gertsena Filial FGBU «NMITs Radiologii» Minzdrava Rossii, 2018 (In Russ.)].
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi: 10.3322/caac.20107
4. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-386. doi: 10.1002/ijc.29210
5. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230-9. doi: 10.1016/S0140-6736(06)69044-2
6. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136(2):376-86. doi: 10.1053/j.gastro.2008.12.015
7. Farthing M, Roberts SE, Samuel DG, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe. United European Gastroenterol J. 2014;2(6):539-43. doi: 10.1177/2050640614554154
8. Rodriguez S, Gaunt TR, Guo Y, et al. Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular gene-centric 50K SNP array. Eur J Hum Genet. 2016;24(1):106-12. doi: 10.1038/ejhg.2015.63
9. Fukuma H, Morshed SA, Watanabe S, et al. Increased expression of cytokines in liver and serum in patients with extrahepatic diseases. J Gastroenterol. 1996;31(4):538-45.
10. Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012;143(3):550-63. doi: 10.1053/j.gastro.2012.07.009
11. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-99. doi: 10.1016/j.cell.2010.01.025
12. Abbas T, Keaton MA, Dutta A. Genomic instability in cancer. Cold Spring Harb Perspect Biol. 2013;5(3):a012914. doi: 10.1101/cshperspect.a012914
13. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1-9. doi: 10.1016/j.critrevonc.2007.07.004
14. Zang J, Yuan Y, Zhang C, Gao J. Elective laparoscopic cholecystectomy without intraoperative cholangiography: role of preoperative magnetic resonance cholangiopancreatography – a retrospective cohort study. BMC Surg. 2016;16(1):45. doi: 10.1186/s12893-016-0159-9
15. Holzheimer RG, Mannick JA, eds. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt; 2001. Accessed July 03, 2019. http://www.ncbi.nlm.nih.gov/books/NBK6880/
16. Mahid SS, Jafri NS, Brangers BC, Minor KS, Hornung CA, Galandiuk S. Meta-analysis of cholecystectomy in symptomatic patients with positive hepatobiliary iminodiacetic acid scan results without gallstones. Arch Surg. 2009;144(2):180-7. doi: 10.1001/archsurg.2008.543
17. Sonne DP, Hare KJ, Martens P, et al. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients. Am J Physiol Gastrointest Liver Physiol. 2013;304(4):G413-419. doi: 10.1152/ajpgi.00435.2012
18. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137-74. doi: 10.1146/ annurev.biochem.72.121801.161712
19. Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med. 1999;159(22):2647-58.
20. Chiang JYL. Bile acids: regulation of synthesis. J Lipid Res. 2009;50(10):1955-66. doi: 10.1194/jlr.R900010-JLR200
21. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry. 1992;31(20):4737-49.
22. Ridlon JM, Kang D-J, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241-59. doi: 10.1194/jlr.R500013-JLR200
23. Chiang JYL. Bile Acid Metabolism and Signaling. Compr Physiol. 2013;3(3):1191-212. doi: 10.1002/cphy.c120023
24. Di Ciaula A, Garruti G, Lunardi Baccetto R, et al. Bile Acid Physiology. Ann Hepatol. 2017;16:S4-S14. doi: 10.5604/01.3001.0010.5493
25. Staley C, Weingarden AR, Khoruts A, Sadowsky MJ. Interaction of Gut Microbiota with Bile Acid Metabolism and its Influence on Disease States. Appl Microbiol Biotechnol. 2017;101(1):47-64. doi: 10.1007/s00253-016-8006-6
26. Chen Y-K, Yeh J-H, Lin C-L, et al. Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study. J Gastroenterol. 2014;49(5):923-31. doi: 10.1007/s00535-013-0846-6
27. Bernstein C, Holubec H, Bhattacharyya AK, et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol. 2011;85(8):863-71. doi: 10.1007/s00204-011-0648-7
28. Reddy BS, Wynder EL. Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer. 1977;39(6):2533-9.
29. Huo X, Juergens S, Zhang X, et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett’s epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2011;301(2):G278-286. doi: 10.1152/ajpgi.00092.2011
30. Wang X, Sun L, Wang X, et al. Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression. Cancer Med. 2017;6(4):788-97. doi: 10.1002/cam4.999
31. Nagathihalli NS, Beesetty Y, Lee W, et al. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. Cancer Res. 2014;74(7):2062-72. doi: 10.1158/0008-5472.CAN-13-2329
32. Quante M, Bhagat G, Abrams JA, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 2012;21(1):36-51. doi: 10.1016/j.ccr.2011.12.004
33. Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. Inflammatory gradient in Barrett’s oesophagus: implications for disease complications. Gut. 2002;51(3):316-22.
34. Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses. 1986;19(1):57-69.
35. Tucker ON, Dannenberg AJ, Yang EK, Fahey TJ. Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis. 2004;25(3):419-23. doi: 10.1093/carcin/bgh010
36. Koga S, Kaibara N, Takeda R. Effect of bile acids on 1,2-dimethylhydrazine-induced colon cancer in rats. Cancer. 1982;50(3):543-7.
37. Zuccato E, Venturi M, Di Leo G, et al. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci. 1993;38(3):514-9.
38. Perez M-J, Briz O. Bile-acid-induced cell injury and protection. World J Gastroenterol. 2009;15(14):1677-89. doi: 10.3748/wjg.15.1677
39. Lagergren J, Mattsson F. Cholecystectomy as a risk factor for oesophageal adenocarcinoma. Br J Surg. 2011;98(8):1133-7. doi: 10.1002/bjs.7504
40. Freedman J, Ye W, Näslund E, Lagergren J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001;121(3):548-53.
41. Ge Z, Zhao C, Wang Y, Qian J. Cholecystectomy and the risk of esophageal and gastric cancer. Saudi Med J. 2012;33(10):1073-9.
42. [Ognerubov NA. Gallstone disease after surgical treatment of gastric cancer: is prophylactic cholecystectomy justified? Vestnik TGU. 2017;22(1):148-54 (In Russ.)]. doi: 10.20310/1810-0198-2017-22-1-148-154
43. Inoue K, Fuchigami A, Higashide S, et al. Gallbladder sludge and stone formation in relation to contractile function after gastrectomy. A prospective study. Ann Surg. 1992;215(1):19-26.
44. Hauters PP, de Neve de Roden A, Pourbaix A, Aupaix F, Coumans P, Therasse G. Cholelithiasis: a serious complication after total gastrectomy. Br J Surg. 1988;75:899-900.
45. Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y. Analysis of risks factors for the development of gallstones after gastrectomy. Br J Surg.2005;92:1399-403. doi: 10.1002/bjs.5117
46. Ichimiya H, Kono S, Ikeda M, Tokudome S, Nakayama F, Kuratsune M. Cancer mortality among patients undergoing cholecystectomy for benign biliary diseases. Jpn J Cancer Res. 1986;77(6):579-83.
47. Freedman J, Lagergren J, Bergström R, Näslund E, Nyrén O. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg. 2000;87(8):1087-93. doi: 10.1046/j.1365-2168.2000.01459.x
48. Kalima T, Sjöberg J. Bile reflux after cholecystectomy. Scand J Gastroenterol Suppl. 1981;67:153-6.
49. Kang SH, Kim YH, Roh YH, et al. Gallstone, cholecystectomy and risk of gastric cancer. Ann Hepatobiliary Pancreat Surg. 2017;21(3):131-7. doi: 10.14701/ahbps.2017.21.3.131
50. Nogueira L, Freedman ND, Engels EA, Warren JL, Castro F, Koshiol J. Gallstones, cholecystectomy, and risk of digestive system cancers. Am J Epidemiol. 2014;179(6):731-9. doi: 10.1093/aje/kwt322
51. Hardt PD, Bretz L, Krauss A, et al. Pathological pancreatic exocrine function and duct morphology in patients with cholelithiasis. Dig Dis Sci. 2001;46(3):536-9.
52. Gong Y, Li S, Tang Y, et al. Cholelithiasis and risk of pancreatic cancer: systematic review and meta-analysis of 21 observational studies. Cancer Causes Control. 2014;25(11):1543-51. doi: 10.1007/s10552-014-0458-3
53. Hyvärinen H, Partanen S. Association of cholecystectomy with abdominal cancers. Hepatogastroenterology. 1987;34(6):280-4.
54. Smith JP, Solomon TE, Bagheri S, Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci. 1990;35(11):1377-84.
55. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57(1):69-76. doi: 10.1016/ j.jhep.2012.02.022
56. Ioannou GN. Cholelithiasis, cholecystectomy, and liver disease. Am J Gastroenterol. 2010;105(6):1364-73. doi: 10.1038/ajg.2009.737
57. Guo L, Mao J, Li Y, et al. Cholelithiasis, cholecystectomy and risk of hepatocellular carcinoma: a meta-analysis. J Cancer Res Ther. 2014;10(4):834-8. doi: 10.4103/0973-1482.135992
58. Wang Y, Xie L-F, Lin J. Gallstones and cholecystectomy in relation to risk of liver cancer. Eur J Cancer Prev. 2019;28(2):61-7. doi: 10.1097/CEJ.0000000000000421
59. Liu Y, He Y, Li T, et al. Risk of primary liver cancer associated with gallstones and cholecystectomy: a meta-analysis. PLoS ONE. 2014;9(10):e109733. doi: 10.1371/journal.pone.0109733
60. Xiong J, Wang Y, Huang H, et al. Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma. Oncotarget. 2017;8(35):59648-57. doi: 10.18632/oncotarget.19570
61. Medavaram S, Zhang Y. Emerging therapies in advanced hepatocellular carcinoma. Exp Hematol Oncol. 2018;7. doi: 10.1186/s40164-018-0109-6
62. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. doi: 10.3322/caac.21442
63. Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29):5282-94. doi: 10.3748/wjg.v23.i29.5282
64. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118-27. doi: 10.1056/NEJMra1001683
65. Johansen C, Chow WH, Jørgensen T, Mellemkjaer L, Engholm G, Olsen JH. Risk of colorectal cancer and other cancers in patients with gall stones. Gut. 1996;39(3):439-43. doi: 10.1136/gut.39.3.439
66. Tavani A, Rosato V, Di Palma F, et al. History of cholelithiasis and cancer risk in a network of case-control studies. Ann Oncol. 2012;23(8):2173-8. doi: 10.1093/annonc/mdr581
67. Deschner EE, Cohen BI, Raicht RF. Acute and chronic effect of dietary cholic acid on colonic epithelial cell proliferation. Digestion. 1981;21(6):290-6. doi: 10.1159/000198579
68. Cohen BI, Raicht RF, Deschner EE, Takahashi M, Sarwal AN, Fazzini E. Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats. J Natl Cancer Inst. 1980;64(3):573-8.
69. Pomare EW, Heaton KW. The effect of cholecystectomy on bile salt metabolism. Gut. 1973;14(10):753-62.
70. El Zoghbi M, Cummings LC. New era of colorectal cancer screening. World J Gastrointest Endosc. 2016;8(5):252-8. doi: 10.4253/wjge.v8.i5.252
71. Berkhout M, Roelofs HMJ, Friederich P, et al. Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study. Transl Res. 2007;150(3):147-9. doi:10.1016/j.trsl.2007.03.009
72. Zhao M-F, Huang P, Ge C-L, Sun T, Ma Z-G, Ye F-F. Conjugated bile acids in gallbladder bile and serum as potential biomarkers for cholesterol polyps and adenomatous polyps. Int J Biol Markers. 2016;31(1):e73-79. doi: 10.5301/jbm.5000173
73. Cheng K, Metry M, Felton J, Shang AC, Drachenberg CB, Xu S, Zhan M, Schumacher J, Guo GL, Polli JE, Raufman JP. Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget. 2018;9(39):25572-85. 
74. Flynn C, Montrose DC, Swank DL, Nakanishi M, Ilsley JN, Rosenberg DW. Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Mol Carcinog. 2007;46(1):60-70. doi: 10.1002/mc.20253
75. Raufman JP, Dawson PA, Rao A, Drachenberg CB, Heath J, Shang AC, Hu S, Zhan M, Polli JE, Cheng K. Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. Carcinogenesis. 2015;36(10):1193-200. doi: 10.1093/carcin/bgv107
76. Wang W, Wang J, Li J, et al. Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction. Front Microbiol. 2018;9. doi: 10.3389/fmicb.2018.01402
77. Galitskiy M, Khomeriki S, Nikiforov P. Expression of proliferation and apoptosis markers in neoplasms of colon mucosa after cholecystectomy. Eksp Klin Gastroenterol. 2009;(5):28-32.
78. Zhang Y, Liu H, Li L, et al. Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies. PLoS ONE. 2017;12(8):e0181852. doi: 10.1371/journal.pone.0181852
79. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology. 1993;105(1):130-41.
80. Xu Y-K, Zhang F-L, Feng T, Li J, Wang Y-H. [Meta-analysis on the correlation of cholecystectomy or cholecystolithiasis to risk of colorectal cancer in Chinese population]. Ai Zheng. 2009;28(7):749-55.
81. Chiong C, Cox MR, Eslick GD. Gallstone disease is associated with rectal cancer: a meta-analysis. Scand J Gastroenterol. 2012;47(5):553-64. doi: 10.3109/00365521.2012.660538
82. Chiong C, Cox MR, Eslick GD. Gallstones are associated with colonic adenoma: a meta-analysis. World J Surg. 2012;36(9):2202-9. doi: 10.1007/s00268-012-1646-5

М.А. Осадчук, А.А. Cвистунов, Е.Д. Миронова, И.Н. Васильева, Н.В. Киреева

ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия

________________________________________________

M.A. Osadchuk, А.А. Svistunov, E.D. Mironova, I.N. Vasil’eva, N.V. Kireeva

Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia